Chemed (CHE) Revenue (2009 - 2026)

Chemed (CHE) has reported Revenue for 18 consecutive years, with $657.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue rose 1.63% year-over-year to $657.5 million; the TTM figure through Mar 2026 stood at $2.5 billion (up 2.07% YoY), while the FY2025 annual figure was $2.5 billion, up 4.06% from the prior year.
• Revenue came in at $657.5 million for Q1 2026 at Chemed, up from $639.3 million in the prior quarter.
• The five-year high for Revenue was $657.5 million in Q1 2026, with the low at $526.5 million in Q3 2022.
• Average Revenue over 5 years is $589.3 million, with a median of $589.2 million recorded in 2024.
• Across the five-year window, Revenue declined 2.26% in 2022 and grew 9.79% in 2025, its largest moves.
• Year by year, Revenue stood at $546.7 million in 2022, then rose by 7.18% to $585.9 million in 2023, then advanced by 9.23% to $640.0 million in 2024, then decreased by 0.1% to $639.3 million in 2025, then climbed by 2.84% to $657.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $657.5 million, $639.3 million, and $624.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.